Skip to content

Impact of Esketamine Infusion Combined with Ultrasound-Guided Thoracic Paravertebral Block on Postoperative Recovery Quality in Patients Undergoing Breast Cancer Surgery

Impact of Esketamine Infusion Combined with Ultrasound-Guided Thoracic Paravertebral Block on Postoperative Recovery Quality in Patients Undergoing Breast Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125705
Enrollment
Unknown
Registered
2026-05-29
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Esketamine combined with paravertebral nerve block group:Received ultrasound-guided paravertebral nerve block with ropivacaine after anesthesia induction, combined with intraoperative continuous infus
Esketamine group:Received ultrasound-guided paravertebral nerve block with an equivalent volume of normal saline after anesthesia induction, combined with intraoperative continuous infusion of esketam
Paravertebral block group:Received ultrasound-guided paravertebral nerve block with ropivacaine after anesthesia induction, combined with intraoperative continuous infusion of an equivalent volume of
Control group:Received ultrasound-guided paravertebral nerve block with normal saline after anesthesia induction, combined with intraoperative continuous infusion of an equivalent volume of normal sal

Sponsors

Affiliated hospital of north sichuan medical college
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with ASA physical status I-III scheduled for elective unilateral modified radical mastectomy or breast-conserving radical mastectomy; 2. Including those undergoing unilateral total mastectomy; 3. Total mastectomy with axillary lymph node dissection; 4. Total mastectomy with sentinel lymph node biopsy; 5. Or breast-conserving surgery with axillary lymph node dissection.

Exclusion criteria

Exclusion criteria: 1. History of opioid use within 3 months prior to enrollment; 2. Previous surgery on the ipsilateral breast; 3. Allergy to local anesthetics or opioids; 4. Planned bilateral surgery; 5. History of major breast reconstruction involving tissue flaps; 6. Contraindications to regional anesthesia; 7. Male patients; 8. Pregnant or breastfeeding women; 9. Use of beta-blockers; 10. Receipt of other analgesic regimens; 11. Inability to comply with the study protocol for any reason.

Design outcomes

Primary

MeasureTime frame
Quality of postoperative recovery;

Secondary

MeasureTime frame
Pain score;Serum levels of cortisol, epinephrine, IL-6, and TNF-a;Time to first ambulation;Postoperative hospital stay;Adverse events;

Countries

China

Contacts

Public ContactZhao Yang

Affiliated hospital of north sichuan medical college

594624370@qq.com+86 182 8176 0941

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026